Latest News
Huimin Zhang of UC Riverside has received a 2025 AFAR Grant for Junior Faculty to study immune ageing, one of six awards this year. The Grants for Junior Faculty programme provides up to US$150,000 to junior faculty for one to two years to support research that will underpin longer-term work on the biology of ageing. [...]
Hospices in England have cut around 300 beds and reduced staff as nearly two-thirds reported deficits, despite rising demand for end-of-life care, a new report has revealed. Services have been reduced across the country, creating what campaigners describe as a postcode lottery in access to palliative care — specialist support for people with life-limiting conditions. [...]
Age Tech World explores the latest business developments in the world of age technology and longevity US$25m fund to reimagine human longevity India-based entrepreneur Deepinder Goyal has announced the launch of Continue Research, supported by a US$25m personal fund dedicated to advancing global longevity science. Continue Research was founded two years ago as an independent [...]
Men must exercise nearly twice as long as women to achieve the same 30 per cent reduction in heart disease risk, according to new research. Women who exercised for 250 minutes a week saw their coronary heart disease risk fall by 30 per cent, while men needed about 530 minutes — nearly nine hours — [...]
Older adults who frequently engage with music may have up to a 39 per cent lower risk of developing dementia, according to new research. Regularly playing an instrument was linked to a 35 per cent reduced risk, while those who both listened to and played music showed a 33 per cent lower risk. The findings [...]
AlayaCare has acquired Nightingale Software to expand its aged care footprint in Australia and New Zealand, pending customary conditions and regulatory approvals. AlayaCare Nightingale’s platform will continue to operate and staff will be retained, with services supported by AlayaCare’s technology, product roadmap and resources. The company says its all-in-one platform offers real-time data insights, personalised [...]
The UK government has announced a plan to diagnose 92 per cent of people with dementia within 18 weeks of a doctor’s referral by 2029 — up from fewer than half today. A £5m research challenge will fund new diagnostic tools, including blood tests, saliva analysis and AI-driven technologies, to speed up detection and improve [...]
US adults scored an average of 60 out of 100 on the new Longevity Preparedness Index (LPI), indicating that most are underprepared to live well as they age. The index measures readiness across eight areas: social connection, daily activities, care, home, community, life transitions, health and finance. Care preparedness scored lowest at 42, while community [...]
Czech company H₂ Medical Technologies, a subsidiary of H₂ Global Group, has received official approval from the State Institute for Drug Control (SÚKL) to begin a clinical study on molecular hydrogen inhalation therapy for patients with mild cognitive impairment (MCI), an early stage of Alzheimer’s disease. The authorisation marks Europe’s first fully approved clinical trial [...]
Canada has conditionally approved Leqembi (lecanemab), the first treatment that targets an underlying cause of early Alzheimer’s disease by removing toxic amyloid beta proteins from the brain. Health Canada issued the Notice of Compliance with Conditions on 27 October for adults with mild cognitive impairment or mild dementia due to Alzheimer’s disease who have confirmed [...]
